Stocks Health care PAHC
NASDAQ · Health carePhibro Animal Health Corp (PAHC)
Phibro Animal Health Corp brought in $1.5B of revenue over the twelve months to September 30, 2026, up 10.1% from a year earlier. Net income was $102.7M, a net margin of 6.7%. Operating cash flow minus capital spending left $9.9M of free cash flow in fiscal 2026. At September 30, 2026 it held $75.5M in cash against $610.9M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.
Key facts about Phibro Animal Health Corp
- Net worth
- Phibro Animal Health Corp has a market value (market cap) of $1.4B at the latest share price, and shareholders' equity of $417.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2026 revenue was $1.5B (+17.1% year on year), with net income of $99.7M. Over the 12 months to September 30, 2026: revenue $1.5B, net income $102.7M.
- Cash flow
- In fiscal 2026 operations brought in $69M of cash; after $59.1M of capital spending, free cash flow was $9.9M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Phibro Animal Health Corp's next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- Phibro Animal Health Corp declared dividends of $0.48 per share in fiscal 2026, a yield of 1.39% at the current price.
What Phibro Animal Health Corp does
Phibro Animal Health Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PAHC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $1.5B | $99.7M | $2.43 | $9.9M |
| 2025 | $1.3B | $48.3M | $1.19 | $41.8M |
| 2024 | $1B | $2.4M | $0.06 | $46.4M |
| 2023 | $977.9M | $32.6M | $0.81 | -$38.5M |
| 2022 | $942.3M | $49.2M | $1.21 | -$5.4M |
| 2021 | $833.4M | $54.4M | $1.34 | $19M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where PAHC ranks in Health care
Dividends
Phibro Animal Health Corp declared $0.48 per share in fiscal 2026. At the current price that is a yield of 1.39%. It paid out $19.5M in cash dividends, 20% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2026 | $0.48 | $19.5M | 20% |
| 2025 | $0.48 | $19.4M | 40% |
| 2024 | $0.48 | $19.4M | 805% |
| 2023 | $0.48 | $19.4M | 60% |
| 2022 | $0.48 | $19.4M | 40% |
| 2021 | $0.48 | $19.4M | 36% |
Latest SEC filings
What Phibro Animal Health Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 4, 2026
- November 4, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 6.3% to $386.8M versus the same quarter last year; diluted EPS $0.72 versus $0.65.
- November 3, 2026Other event 8-K
- October 19, 2026Passive stake changed SCHEDULE 13G/A
- September 18, 2026
- September 18, 2026Additional proxy material DEFA14A
- September 18, 2026Proxy statement DEF 14A
- August 26, 2026
- August 26, 2026Annual report 10-K · period to June 30, 2026Revenue rose 17% to $1.5B versus the prior year; diluted EPS $2.43 versus $1.19.
- August 6, 2026Passive stake changed SCHEDULE 13G/A
What is PAHC worth? A DCF from its reported cash flow
Insider trades
What the people running Phibro Animal Health Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 6, 2026 | Miller Larry LeeChief Operating Officer | Received as pay | 3,726 | - |
| August 6, 2026 | David GlennChief Financial Officer | Received as pay | 3,482 | - |
| August 6, 2026 | Bendheim Daniel MPresident and CEO, Director | Received as pay | 11,699 | - |
| August 6, 2026 | Escudero Lisa AnnSee Remarks | Received as pay | 1,547 | - |
| August 6, 2026 | Bendheim JackExecutive Chairman, Director, 10% owner | Received as pay | 12,103 | - |
| August 6, 2026 | Weinstein JudithSee Remarks | Received as pay | 2,478 | - |
| August 6, 2026 | BENDHEIM JonathanDirector | Received as pay | 2,716 | - |
| August 6, 2026 | Miller Larry LeeChief Operating Officer | Received as pay | 3,522 | - |
Who owns PAHC
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| BFI Co., LLC13D, may seek influence with 1 related filers | 48.2% | May 22, 2026 |
| Fmr LLC13G, passive with 1 related filers | 15% | August 6, 2026 |
| Vanguard Capital Management13G, passive | 5.06% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 208 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 3,219,040 | -34,808 |
| Fmr LLC | 3,160,281 | +987,155 |
| State Street Corp | 1,038,382 | +88,349 |
| Millennium Management LLC | 936,701 | +880,882 |
| Vanguard Capital Management LLC | 923,318 | +32,035 |
| Geode Capital Management, LLC | 657,350 | +52,702 |
| Dimensional Fund Advisors LP | 531,087 | +23,235 |
| Vanguard Portfolio Management LLC | 508,486 | +18,144 |
| Renaissance Technologies LLC | 480,500 | -96,235 |
| CastleKnight Management LP | 461,322 | +385,427 |
| Morgan Stanley | 412,634 | +21,447 |
| Dana Investment Advisors, Inc. | 387,867 | +100,143 |
| Invesco Ltd. | 336,329 | +5,352 |
| Nuveen, LLC | 314,079 | -141,812 |
| Oberweis Asset Management Inc/ | 311,100 | +34,000 |
| Ranger Investment Management, L.P. | 292,410 | +13,935 |
| Charles Schwab Investment Management Inc | 260,861 | -3,401 |
| Bank of New York Mellon Corp | 254,380 | +24,389 |
| Allspring Global Investments Holdings, LLC | 254,234 | -31,938 |
| Northern Trust Corp | 237,528 | +18,127 |
Insiders
9 insiders reported holding 249,036 shares in total, about $8.6M at the last price.
| Holder | Shares |
|---|---|
| Bendheim JackPresident and CEO, Director, 10% owner | 82,79256,152 held indirectly |
| David GlennChief Financial Officer | 54,959 |
| Corcoran E ThomasDirector | 41,459 |
| Miller Larry LeeChief Operating Officer | 38,275 |
| Bendheim Daniel MPresident and CEO, Director | 15,177 |
| BENDHEIM JonathanDirector | 5,984 |
| Weinstein JudithSee Remarks | 5,453 |
| Escudero Lisa AnnSee Remarks | 3,434 |
| Rodriguez PatrickVP Finance and Treasurer | 1,503 |
Questions about PAHC
What does Phibro Animal Health Corp do?
Phibro Animal Health Corp is a company in the Health care sector, listed on NASDAQ as PAHC. Its shares trade on NASDAQ under the ticker PAHC.
What is Phibro Animal Health Corp's net worth?
Phibro Animal Health Corp has a market value (market cap) of $1.4B at the latest share price, and shareholders' equity of $417.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Phibro Animal Health Corp profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $102.7M on revenue of $1.5B, a net margin of 6.7%.
How much revenue does Phibro Animal Health Corp make?
Over the twelve months to September 30, 2026 Phibro Animal Health Corp reported revenue of $1.5B. That is 10.1% more than a year earlier.
When did Phibro Animal Health Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to September 30, 2026.
When is Phibro Animal Health Corp's next earnings report?
Phibro Animal Health Corp's next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does Phibro Animal Health Corp pay a dividend?
Yes. Phibro Animal Health Corp declared dividends of $0.48 per share in fiscal 2026, a yield of 1.39% at the current price.
Similar companies
Compare PAHC with
Follow PAHC
Get an email when Phibro Animal Health Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Phibro Animal Health Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.